Carisma Therapeutics Inc (CARM)

12:23 PM

How high can Carisma Therapeutics Inc. stock price go in 2025Triple-digit returns - jammulinksnews.com

12:23 PM

Jul 24, 2025

Is Carisma Therapeutics Inc. a good long term investmentFree Real-Time Stock Data - Autocar Professional

Jul 24, 2025

Jul 24, 2025

Carisma Therapeutics Inc. Stock Analysis and ForecastFree Popular Stock Recommendations - PrintWeekIndia

Jul 24, 2025

Jul 23, 2025

What analysts say about Carisma Therapeutics Inc. stockExtraordinary market timing - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

What drives Carisma Therapeutics Inc. stock priceFree Stock Market Real-Time Monitoring - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Published on: 2025-07-22 17:12:50 - jammulinksnews.com

Jul 22, 2025

Jul 19, 2025

Carisma Therapeutics Transfers Listing to Nasdaq Capital Market - TipRanks

Jul 19, 2025

Jul 16, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVEE, CARM, HLGN on Behalf of Shareholders - Benzinga

Jul 16, 2025

Jul 16, 2025

How Carisma Therapeutics Inc. stock performs during market volatility200 Percent Profit Outlook - Newser

Jul 16, 2025

Jul 15, 2025

What makes Carisma Therapeutics Inc. stock price move sharplyFree Top-Rated Stock Analysis - Newser

Jul 15, 2025

Jul 15, 2025

Why Carisma Therapeutics Inc. stock attracts strong analyst attentionFree VIP Investment Strategies - Newser

Jul 15, 2025

Jul 14, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: TURN, HLGN, CARM, and GNTY - The Malaysian Reserve

Jul 14, 2025

Jul 05, 2025

Investor Rights Law Firm Investigates Couchbase, Carisma, Enzo Biochem Merger Deals. - AInvest

Jul 05, 2025

Jul 04, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE - The Malaysian Reserve

Jul 04, 2025

Jul 01, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMS, BASE, CARM, ENZB on Behalf of Shareholders - Morningstar

Jul 01, 2025

Jun 30, 2025

Carisma Therapeutics Inc. (NASDAQ:CARM) Given Average Recommendation of “Hold” by Brokerages - Defense World

Jun 30, 2025

Jun 27, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jun 27, 2025

Jun 27, 2025

Deal Watch: Novartis To Develop Cardiovascular Therapies With ProFound - insights.citeline.com

Jun 27, 2025

Jun 26, 2025

Carisma Therapeutics and OrthoCellix Merge to Advance Regenerative Cell Therapy for Orthopedic Diseases - MSN

Jun 26, 2025

Jun 25, 2025

After laying off most of its staff, struggling Carisma Therapeutics finds a merger partner - The Business Journals

Jun 25, 2025

Jun 24, 2025

Carisma Therapeutics, OrthoCellix enter definitive merger agreement - Yahoo Finance

Jun 24, 2025

Jun 23, 2025

Carisma Therapeutics stock soars after proposed merger with OrthoCellix - Investing.com India

Jun 23, 2025

Jun 22, 2025

CARISMA Therapeutics Plummets 12%: What Drives a Crash Without News? - AInvest

Jun 22, 2025

Jun 21, 2025

Carisma Therapeutics' 12% Drop: A Mystery Unveiled Through Order Flow and Peer Dynamics - AInvest

Jun 21, 2025

Jun 20, 2025

CARISMA Therapeutics Plunges 10.36% Amid Market Volatility - AInvest

Jun 20, 2025

Jun 15, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Sold by Millennium Management LLC - Defense World

Jun 15, 2025

Jun 15, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Stock Position Decreased by Millennium Management LLC - Defense World

Jun 15, 2025

Jun 15, 2025

Millennium Management LLC Takes Position in Marker Therapeutics, Inc. (NASDAQ:MRKR) - Defense World

Jun 15, 2025

Jun 12, 2025

Carisma Therapeutics Secures Nasdaq Listing Approval - TipRanks

Jun 12, 2025

Jun 11, 2025

Is the 250% Carisma Therapeutics Stock (CARM) Surge a Sucker’s Rally? - The Globe and Mail

Jun 11, 2025

Jun 11, 2025

Dow Rises Over 50 Points; US Inflation Rate Increases In May - Benzinga

Jun 11, 2025

Jun 11, 2025

Carisma Therapeutics Stock (CARM) Retreats 35% After a Massive Rally - TipRanks

Jun 11, 2025